Global Therapeutics Pty Ltd Sustainability Profile
Global Therapeutics Pty Ltd, headquartered in Australia, is a leading player in the natural health industry, specialising in the development and distribution of high-quality herbal and nutritional products. Founded in 2000, the company has established a strong presence across major operational regions, including Asia and Europe, and has achieved significant milestones in product innovation and market expansion. The company’s core offerings include a diverse range of herbal supplements and natural remedies, distinguished by their commitment to quality and efficacy. Global Therapeutics is renowned for its unique formulations that blend traditional wisdom with modern science, catering to the growing demand for natural health solutions. With a solid market position and a reputation for excellence, Global Therapeutics continues to set benchmarks in the industry, contributing to the well-being of consumers worldwide.
DitchCarbon Score
How does Global Therapeutics Pty Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Global Therapeutics Pty Ltd's score of 6 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Global Therapeutics Pty Ltd's reported carbon emissions
Global Therapeutics Pty Ltd, headquartered in Australia, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of McPherson's Limited, which may influence its climate commitments and reporting practices. While Global Therapeutics Pty Ltd has not established specific reduction targets or initiatives, it is important to note that emissions data and climate strategies may be inherited from its parent company, McPherson's Limited. This relationship suggests that any climate commitments or performance metrics may align with those of McPherson's Limited, although specific details are not provided. As part of the broader industry context, companies like Global Therapeutics are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. The absence of specific data highlights the need for enhanced climate action and accountability within the organisation.
How Carbon Intensive is Global Therapeutics Pty Ltd's Industry?
How Carbon Intensive is Global Therapeutics Pty Ltd's Location?
Global Therapeutics Pty Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Global Therapeutics Pty Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
